In inflammatory breast cancer (IBC), tumor cells interact with immune suppressing M2-TAM leading to the production of high levels of IL-8 and CCL18 chemokines that in turn activate STAT3, which induces a CSCs-like phenotype in IBC cells and drives EMT during IBC progression (193). This evidence concerns the gene STAT3 and inflammatory breast carcinoma.